Susquehanna International Group
IMNM icon

Susquehanna International Group’s Immunome IMNM Stock Holding History

Susquehanna International Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Sell
162,400
-270,300
-62% -$6.02M ﹤0.01% 4911
2025
Q4 		$9.29M Buy
432,700
+236,900
+121% +$4.16M ﹤0.01% 3144
2025
Q3 		$2.29M Buy
195,800
+172,500
+740% +$1.72M ﹤0.01% 5487
2025
Q2 		$217K Buy
23,300
+2,400
+11% +$19.7K ﹤0.01% 11049
2025
Q1 		$141K Buy
20,900
+3,300
+19% +$31.7K ﹤0.01% 11280
2024
Q4 		$187K Buy
+17,600
New +$213K ﹤0.01% 10802
2024
Q3 		– Sell
-39,100
Closed -$473K – 12462
2024
Q2 		$473K Buy
39,100
+14,400
+58% +$225K ﹤0.01% 8395
2024
Q1 		$610K Sell
24,700
-20,700
-46% -$420K ﹤0.01% 8038
2023
Q4 		$486K Buy
45,400
+6,900
+18% +$57.4K ﹤0.01% 8731
2023
Q3 		$321K Buy
38,500
+27,900
+263% +$205K ﹤0.01% 9206
2023
Q2 		$83.8K Buy
+10,600
New +$58K ﹤0.01% 11073
2022
Q4 		– Sell
-24,300
Closed -$108K – 12998
2022
Q3 		$108K Buy
+24,300
New +$114K ﹤0.01% 11625
2022
Q1 		– Sell
-47,300
Closed -$613K – 13460
2021
Q4 		$613K Buy
47,300
+13,000
+38% +$232K ﹤0.01% 8613
2021
Q3 		$835K Buy
+34,300
New +$598K ﹤0.01% 8021

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Susquehanna International Group's IMNM Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunome (IMNM) stake by 65% in Q1 2026, selling an estimated $2.49M and leaving 58,985 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #7248.

Susquehanna International Group first reported a position in IMNM in Q3 2021 and has held it in 18 quarters since. The position peaked at $9.27M in Q1 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Susquehanna International Group held 58,985 shares of Immunome worth $1.29M as of Q1 2026.
  • Susquehanna International Group sold 111,929 Immunome shares in Q1 2026, an estimated $2.49M.
  • Immunome made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7248 holding.
  • Susquehanna International Group first reported a position in Immunome in Q3 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's Immunome position peaked at $9.27M in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.